Selected Cancer-Related Publications:
Gulley JL, Madan RA, Tsang KY, Arlen PM, Camphausen K, Mohebtash M, Kamrava M, Schlom J, Citrin D. A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver. Expert Opin Biol Ther. 2011 Nov;11(11):1409-18. Epub 2011 Aug 28.
Wuthrick EJ, Kamrava M, Curran WJ Jr, Werner-Wasik M, Camphausen KA, Hyslop T, Axelrod R, Andrews DW, Glass J, Machtay M, Dicker AP. A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies. Cancer. 2011 Jun 3. doi: 10.1002/cncr.26216. [Epub ahead of print]
Kamrava M, Gius D, Casagrande G, Kohn E. Will targeting insulin growth factor help us or hurt us?: An oncologist's perspective. Ageing Res Rev. 2011 Jan;10(1):62-70. Epub 2009 Nov 5.
Kamrava M, Bernstein MB, Camphausen K, Hodge JW. Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination? Mol Biosyst. 2009 Nov;5(11):1262-70. Epub 2009 Aug 27.
Kamrava M, Tsang KY, Madan RA, Kaushal A, Coleman CN, Gulley J. Long-term survival and PSA control with radiation and immunotherapy for node positive prostate cancer. Clin Dev Immunol. 2009;2009:363914. Epub 2010 Mar 8.